Overview

EMBL Ventures is an independent venture capital investor that manages two Funds with a total of €66 million capital on behalf of major European institutional and private investors. EMBL Ventures' close relationship with the European Molecular Biology Laboratory (EMBL) and its technology transfer organization EMBL Enterprise Management Technology Transfer GmbH (EMBLEM) allows it to finance disruptive technologies in an entrepreneurial start-up environment, aiming ultimately for a transaction with a partner that is seeking to acquire external product innovation. EMBL Ventures is exclusively focused on life-science investments.

"I met the people at EMBL Ventures way back prior to our first round of financing. They had a strong scientific as well as entrepreneur background and showed a hands-on approach right from the start. Moreover, they have maintained this spirit over the years: they have never lost interest, have never stopped challenging the management (in a positive way) and have always stayed fully committed to our company."

Dr. Harpreet Singh; Founder & CSO, Immatics Biotechnologies, Tübingen